ABSTRACT
The purpose of the case study was substantiation of a differential intensive care in abdominal sepsis with respect to its clinical-and-pathogenetic variations. Retro- and prospective clinical-and-biochemical parameters were investigated in 60 patients with disseminated peritonitis and abdominal sepsis. The patients were shared between 3 groups with respect to their clinical-and-laboratory findings. Clinical-and-pathogenetic types were defined for the clinical course of abdominal sepsis (AS). It was found as necessary to add enteral detoxication to the combined intensive care scheme in type 1 AS. A single-stage intravenous perftoran infusion plus enteral detoxication are required in type 2 AS. And in type 3 AS, the therapeutic scheme should be expanded through intravenous infusion of perftoran with subsequent enteral detoxication.